Assignee
SYNTHON BIOPHARMACEUTICALS BV
NL·10 granted patents·2 pending applications·54 citations·filing 2012–2019
Top patents by PatentIndex Score
12 records- 0191US9421278B2Duocarmycin ADCS showing improved in vivo antitumor activitySYNTHON BIOPHARMACEUTICALS BV·Filed 2015·Granted Aug 23, 2016·14 cites·10 claims
- 0290US9427480B2Duocarmycin ADCs for use in treatment of endometrial cancerSYNTHON BIOPHARMACEUTICALS BV·Filed 2015·Granted Aug 30, 2016·13 cites·11 claims
- 0387US11136633B2Site-specific conjugation of linker drugs to antibodies and resulting ADCSSYNTHON BIOPHARMACEUTICALS BV·Filed 2019·Granted Oct 5, 2021·2 cites·20 claims
- 0485US10092659B2Duocarmycin ADCs for use in treatment of endometrial cancerSYNTHON BIOPHARMACEUTICALS BV·Filed 2016·Granted Oct 9, 2018·6 cites·23 claims
- 0584US9573996B2Monoclonal antibodies to human proinflammatory cytokines and methods for treating inflammatory diseasesSYNTHON BIOPHARMACEUTICALS BV·Filed 2012·Granted Feb 21, 2017·6 cites·24 claims
- 0683US10407743B2Site-specific conjugation of linker drugs to antibodies and resulting ADCsSYNTHON BIOPHARMACEUTICALS BV·Filed 2015·Granted Sep 10, 2019·4 cites·15 claims
- 0783US9890159B2Process for making duocarmycin prodrugsSYNTHON BIOPHARMACEUTICALS BV·Filed 2014·Granted Feb 13, 2018·4 cites·14 claims
- 0878US9580501B2Anti-TNF alpha monoclonal secretory IgA antibodies and methods for treating inflammatory diseasesSYNTHON BIOPHARMACEUTICALS BV·Filed 2012·Granted Feb 28, 2017·5 cites·21 claims
- 0966US10603387B2Duocarmycin ADCs showing improved in vivo antitumor activitySYNTHON BIOPHARMACEUTICALS BV·Filed 2017·Granted Mar 31, 2020·0 cites·13 claims
- 1052US2017014525A1Duocarmycin adcs showing improved in vivo antitumor activitySYNTHON BIOPHARMACEUTICALS BV·Filed 2016·Application pending·0 cites
- 1133US2017320965A1Pan-reactive antibodies to duocarmycinsSYNTHON BIOPHARMACEUTICALS BV·Filed 2015·Application pending·0 cites
- 1220US10266606B2Method for purifying Cys-linked antibody-drug conjugatesSYNTHON BIOPHARMACEUTICALS BV·Filed 2015·Granted Apr 23, 2019·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when SYNTHON BIOPHARMACEUTICALS BV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →